NewsBenzingaPharming Receives U.K. Approval For Joenja In Children Aged 4 To 11 With APDS, Supported By Pediatric Clinical Program Data; Marks Step In Expansion Across Age Groups And Markets Pharming Receives U.K. Approval For Joenja In Children Aged 4 To 11 With APDS, Supported By Pediatric Clinical Program Data; Marks Step In Expansion Across Age Groups And Markets Benzinga 2026.11.06 06:17 (GMT+0) Open on Benzinga Other news Rosenblatt Maintains Buy on Applied Optoelectronics, Lowers Price Target to $115 Needham Maintains Buy on Core Scientific, Lowers Price Target to $28 Needham Maintains Buy on Diodes, Lowers Price Target to $100 Needham Maintains Buy on Veeva Systems, Raises Price Target to $360 Enbridge Q3 Adj. EPS $0.35 Misses $0.36 Estimate, Sales $15.062B Beat $10.320B Estimate HC Wainwright & Co. Maintains Buy on Revolution Medicines, Raises Price Target to $350
